Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by ÖSTENSSON, A.
Right arrow Articles by GEBOREK, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ÖSTENSSON, A.
Right arrow Articles by GEBOREK, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1991 British Society for Rheumatology

other

SEPTIC ARTHRITIS AS A NON-SURGICAL COMPLICATION IN RHEUMATOID ARTHRITIS: RELATION TO DISEASE SEVERITY AND THERAPY

A. ÖSTENSSON and P. GEBOREK

Department of Rheumatology, University Hospital of Lund

Correspondence to: Correspondence to Dr P. Geborek, Department of Rheumatology, Lund University Hospital, S-221 85 Lund, Sweden

More aggressive therapy including cytotoxic drugs is increasingly used in the treatment of rheumatoid arthritis (RA), and may confer increased susceptibility to infections. Septic arthritis is one infectious complication known to be over-represented in RA. We studied the impact of disease severity and medication in a group of nine RA patients with proven septic arthritis, excluding those occurring as a complication of orthopaedic surgery. Two control groups were used for comparison. The septic arthritis patients were functionally more incapacitated and more often treated with cytotoxic drugs. Six of the nine septic arthritis patients had received an intra-articular injection into the infected joint within 3 months prior to the onset of the septic arthritis. Only one of these occurred immediately after arthrocentesis. The annual frequency of septic arthritis was approximately 0.2%. During the 4-year period studied the frequency was 0.5%. When related to the number of glucocorticosteroid injections, a frequency of 1 per 2000 injections was found when late septic arthritis was included. The high frequency of delayed septic arthritis after intra-articular glucocorticosteroid administration should alert physicians to this complication.

KEY WORDS: Rheumatoid arthritis, Septic arthritis, Functional class, Immunosuppression, Cytostatics, Glucocortico-steroid, Arthrocentesis


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Ann Rheum DisHome page
A J Geirsson, S Statkevicius, and A Vikingsson
Septic arthritis in Iceland 1990-2002: increasing incidence due to iatrogenic infections
Ann Rheum Dis, May 1, 2008; 67(5): 638 - 643.
[Abstract] [Full Text] [PDF]

Home page
 CMAJHome page
R. B. Kherani and K. Shojania
Septic arthritis in patients with pre-existing inflammatory arthritis
Can. Med. Assoc. J., May 22, 2007; 176(11): 1605 - 1608.
[Full Text] [PDF]

Home page
 J. Immunol.Home page
I. B. McInnes, B. Leung, X.-Q. Wei, C. C. Gemmell, and F. Y. Liew
Septic Arthritis Following Staphylococcus aureus Infection in Mice Lacking Inducible Nitric Oxide Synthase
J. Immunol., January 1, 1998; 160(1): 308 - 315.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
C. J E Kaandorp, H. J Dinant, M. A F J van de Laar, H. J B. Moens, A P. A Prins, and B. A C Dijkmans
Incidence and sources of native and prosthetic joint infection: a community based prospective survey
Ann Rheum Dis, August 1, 1997; 56(8): 470 - 475.
[Abstract] [Full Text]

Home page
 DTBHome page
Articular and periarticular corticosteroid injections
DTB, September 1, 1995; 33(9): 67 - 70.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.